These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

363 related items for PubMed ID: 3926587

  • 1. [Genetic polymorphism of the hepatic metabolism of drugs].
    Larrey D, Pessayre D, Benhamou JP.
    Gastroenterol Clin Biol; 1985; 9(6-7):522-31. PubMed ID: 3926587
    [No Abstract] [Full Text] [Related]

  • 2. Inherited defects of hepatic drug metabolism.
    Küpfer A, Preisig R.
    Semin Liver Dis; 1983 Nov; 3(4):341-54. PubMed ID: 6417793
    [No Abstract] [Full Text] [Related]

  • 3. Pharmacogenetic polymorphism of drug metabolism.
    Paxton JW.
    N Z Med J; 1984 Aug 22; 97(762):567-9. PubMed ID: 6591031
    [No Abstract] [Full Text] [Related]

  • 4. [Genetic polymorphism of oxidative drug metabolism. Therapeutic and toxicologic implications].
    Eichelbaum M.
    Internist (Berl); 1983 Mar 22; 24(3):117-27. PubMed ID: 6135670
    [No Abstract] [Full Text] [Related]

  • 5. Polymorphic oxidation of debrisoquine and sparteine.
    Eichelbaum M.
    Prog Clin Biol Res; 1986 Mar 22; 214():157-67. PubMed ID: 3523506
    [No Abstract] [Full Text] [Related]

  • 6. [Genetic polymorphism of drug oxidation].
    Heller FR, Leclercq V, Harvengt C.
    Acta Gastroenterol Belg; 1988 Mar 22; 51(1):91-101. PubMed ID: 3055790
    [No Abstract] [Full Text] [Related]

  • 7. [Clinical aspects of the polymorphism of oxidation phenotype].
    Mrozikiewicz PM.
    Pol Tyg Lek; 1988 Mar 22; 47(27-28):608-10. PubMed ID: 1488339
    [No Abstract] [Full Text] [Related]

  • 8. [Heritable polymorphisms in oxidative drug metabolism].
    Kallio J.
    Duodecim; 1990 Mar 22; 106(5):408-14. PubMed ID: 1670108
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Pharmacogenetics of oxidation reactions of drugs].
    Jacqz-Aigrain E.
    Arch Fr Pediatr; 1989 Jan 22; 46(1):59-65. PubMed ID: 2653266
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The relationship between imipramine metabolism and the sparteine oxidation polymorphism.
    Brøsen K.
    Dan Med Bull; 1988 Oct 22; 35(5):460-8. PubMed ID: 3066590
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Relationship between oxidative metabolism of 2-acetylaminofluorene, debrisoquine, bufuralol, and aldrin in human liver microsomes.
    McManus ME, Boobis AR, Minchin RF, Schwartz DM, Murray S, Davies DS, Thorgeirsson SS.
    Cancer Res; 1984 Dec 22; 44(12 Pt 1):5692-7. PubMed ID: 6498831
    [Abstract] [Full Text] [Related]

  • 18. Cytochrome P450 polymorphism--molecular, metabolic, and pharmacogenetic aspects. III. Influence of CYP genetic polymorphism on population differentiation of drug metabolism phenotype.
    Tomaszewski P, Kubiak-Tomaszewska G, Łukaszkiewicz J, Pachecka J.
    Acta Pol Pharm; 2008 Dec 22; 65(3):319-29. PubMed ID: 18646551
    [Abstract] [Full Text] [Related]

  • 19. [Liver and metabolism of drugs].
    Darnis F.
    Cah Med; 1974 Oct 15; 15(10):637-43. PubMed ID: 4455367
    [No Abstract] [Full Text] [Related]

  • 20. Genes and the response to drugs.
    Caraco Y.
    N Engl J Med; 2004 Dec 30; 351(27):2867-9. PubMed ID: 15625340
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.